By Amanda Bronstad | July 5, 2022
U.S. District Judge David Faber, in a bench trial that concluded last year in the Southern District of West Virginia, sided with distributors McKesson, Cardinal Health and AmerisourceBergen in a 184-page decision about the opioid crisis.
By Amanda Bronstad | June 27, 2022
Monday's settlement comes after the Oklahoma Supreme Court reversed a $465 million judgment the state obtained against manufacturer Johnson & Johnson's Janssen Pharmaceuticals.
By Scott Graham | June 14, 2022
The Federal Circuit ruled that a patent on a CAR-T treatment did not meet patent law's written description requirement. Jones Day and Irell & Manella are arguing for Bristol-Myers Squibb that the Federal Circuit has added judicial requirements to the statute that are virtually impossible for life sciences companies to meet.
By Allison Dunn | June 7, 2022
The court ruled "the policies underpinning the learned intermediary doctrine remain true today."
By Scott Graham | June 6, 2022
Three Federal Circuit judges suggest that the language of the Patent Act limits inventors to human beings. Judge Richard Taranto adds that it's "not self-evident" that extending inventorship to machines would be good policy, either.
By Mason Lawlor | May 6, 2022
The Department of Justice, along with state law enforcement, has brought criminal charges against 14 defendants, 12 of them medical professionals, for the illegal sale of opioids.
By Amanda Bronstad | May 5, 2022
Another opioid trial began on April 25 in San Francisco against Walgreens, as well as manufacturers Allergan and Teva, and Teva's distribution subsidiary Anda.
By Amanda Bronstad | May 3, 2022
Tuesday's announcement, from Attorney General Bob Ferguson, comes after the state wrapped up a bench trial against the distributors last month but before King County Superior Court Judge Michael Scott had ruled on the case.
By Jane Wester | April 29, 2022
A Davis Polk attorney representing Purdue argued that the third-party release should be approved, because it is a way of maximizing recovery for people affected by the opioid crisis.
By Amanda Bronstad | April 20, 2022
San Francisco City Attorney David Chiu, at a press conference on Wednesday, said drug companies "flooded San Francisco with prescription opioids," creating a public nuisance. One defendant, Endo, settled for $10 million.
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Mid sized NYC Personal Injury Defense Firm seeking to immediately hire several attorneys to join our firm. Preferred candidates are those w...
Mid-size Parsippany based law firm with a statewide practice is searching for a full-time motivated associate litigation attorney with 3-5 y...
Description: Fox Rothschild has an opening in Princeton, NJ for an associate in the Litigation Department. The ideal candidate will have tw...